Osiris Provides Update Regarding NASDAQ Listing Matters
Osiris Therapeutics, Inc. today provided an update regarding the status of its compliance with the Listing Rules of the NASDAQ Stock Market . As previously disclosed, the Company participated in a hearing before the NASDAQ Hearings Panel on November 10, 2016 in connection with the Company's late filings and the Company's anticipated financial restatement relating to prior periods.
from Biotech News
0 Comments